PubHive streamlines pharmacovigilance inefficiencies with AI-powered automation, enhancing operational efficiency and compliance and replacing trackers while delivering cost-effective solutions backed by over 20 years of industry expertise.
PubHive, PubHive Ltd., a leading provider of an AI-powered enterprise scientific literature management and safety Information Workflow Platform for pre-market and post-market surveillance, service providers / CROs, regulatory compliance, and signal management, proudly announces its role as a Gold Sponsor at the upcoming World Drug Safety Congress, to be held on October 9th and 10th in Amsterdam. This prestigious event gathers global pharmaceutical and healthcare professionals to discuss advancements and challenges in drug safety and pharmacovigilance.
This premier event brings together key stakeholders in the drug safety and pharmacovigilance fields. PubHive will showcase its innovative platform designed to empower CROs and life science companies, specifically Small and Medium Enterprises (SMEs), to optimize their pharmacovigilance workflows.
Automated and Efficient Solutions for SMEs:
PubHive’s automated platform offers a comprehensive suite of features for SMEs, addressing their unique challenges in managing post-market safety data:
- Centralized Literature Review and Signal Detection: PubHive’s Pulse Literature platform facilitates efficient global and local literature screening, utilizing AI-powered search and automated signal detection to prioritize potential safety concerns . This empowers SMEs to effectively monitor safety data without requiring extensive resources.
- Streamlined Aggregate Safety Reporting: PubHive Pulse Aggregate Safety Reporting Hub provide a centralized platform for managing Individual Case Safety Reports (ICSRs) and fulfilling regulatory reporting obligations. This simplifies the process for SMEs, ensuring compliance and timely reporting.
- Enhanced Signal Management and Regulatory Compliance: PubHive’s robust safety and regulatory tools support SMEs in efficiently managing signals, conducting thorough investigations, and generating comprehensive safety reports, ensuring adherence to global pharmacovigilance guidelines.
Raj Vaghela Presents on Optimizing Signal Detection:
Raj Vaghela, CEO of PubHive, will be a featured speaker on October 10th at 12:05 PM in the session “Automated and centralised approach to enhance signal detection and surveillance efficiency for SMEs.” He will discuss the challenges faced by SMEs in signal detection and demonstrate how PubHive’s automated platform provides an efficient and cost-effective solution.
Join PubHive at Booth #21:
PubHive invites attendees to visit Booth #21 at the World Drug Safety Congress Europe. The PubHive team will be available to discuss their solutions and answer questions about how they can help streamline pharmacovigilance processes for SMEs.
PubHive is committed to providing innovative solutions that drive efficiency, collaboration, and productivity within the life science industry. For more information about PubHive Navigator and to explore its capabilities, please visit the PubHive website at https://pubhive.com. Details about the World Drug Safety Congress can be found here. #worlddrugsafetycongress #wdsc #wdsc2024 #pubhive
